Overexpression of elongation factor-1γ protein in colorectal carcinoma

Sandip Mathur, Karen R. Cleary, Nikhil Inamdar, Yeul Hong Kim, Peter Steck, Marsha L. Frazier

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

BACKGROUND. Elongation factor-1 (EF-1) is a cellular protein that plays a role in protein synthesis by mediating the transfer of aminoacyl-tRNA to 80S ribosomes. It is comprised of four subunits: α, β, γ, and δ. EF-1γ is a substrate for the maturation-promoting factor, which determines entry into the M-phase of the cell cycle in all eukaryotic cells. Previously, the authors showed that EF-1γ RNA is overexpressed in a high proportion of colorectal carcinomas. At that time, there were no antibodies to EF-1γ, so the EF-1γ protein could not be examined. Because levels of RNA do not always parallel the levels of the protein it encodes, it was important to develop antibodies to EF-1γ to examine its expression at the protein level in colorectal carcinoma. METHODS. Twenty-nine patients undergoing surgical resection for colorectal adenocarcinoma were studied. A polyclonal antibody to EF-1γ in rabbit was prepared. Tumors and normal-appearing mucosa distant from the tumor (≤10 cm) were obtained from each patient. Cytosolic proteins were extracted from the tissues and examined by Western blot analysis with the EF-1γ antibody. Colonic tumors also were studied by immunohistochemical analysis with another EF-1γ polyclonal antibody. RESULTS. Using Western blot analysis, the authors observed greater expression of EF-1γ in the tumors than in the more distal normal-appearing mucosa. Overexpression was not observed in the patients with the two Dukes Stage A tumors, but was observed in four of ten patients with Dukes Stage B tumors, seven of eight patients with Dukes Stage C tumors, and six of nine patients with Dukes Stage D tumors. Overall, 17 of 29 patients (59%) were found to have overexpression of EF-1γ. Using immunohistochemical analysis, EF-1γ protein was shown to be located predominantly in tumor epithelium rather than the stroma or infiltrating mononuclear cells. CONCLUSIONS. Previous studies showed that EF- 1γ mRNA frequently is overexpressed in colorectal adenocarcinoma. This study showed that EF-1γ also was overexpressed at the protein level in colorectal adenocarcinoma relative to more distal normal-appearing mucosa from the same patient. Immunohistochemical analysis demonstrated that this protein was expressed predominantly in the tumor epithelial cells and therefore was not derived from cells involved in the desmoplastic response.

Original languageEnglish
Pages (from-to)816-821
Number of pages6
JournalCancer
Volume82
Issue number5
DOIs
Publication statusPublished - 1998 Mar 1
Externally publishedYes

Fingerprint

Peptide Elongation Factor 1
Colorectal Neoplasms
Proteins
Neoplasms
Antibodies
Mucous Membrane
Adenocarcinoma
Western Blotting
Maturation-Promoting Factor
RNA
Eukaryotic Cells
Transfer RNA
Ribosomes

Keywords

  • Colon carcinoma
  • Elongation factor-1γ
  • Gene overexpression
  • Normal- appearing mucosa

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Overexpression of elongation factor-1γ protein in colorectal carcinoma. / Mathur, Sandip; Cleary, Karen R.; Inamdar, Nikhil; Kim, Yeul Hong; Steck, Peter; Frazier, Marsha L.

In: Cancer, Vol. 82, No. 5, 01.03.1998, p. 816-821.

Research output: Contribution to journalArticle

Mathur, Sandip ; Cleary, Karen R. ; Inamdar, Nikhil ; Kim, Yeul Hong ; Steck, Peter ; Frazier, Marsha L. / Overexpression of elongation factor-1γ protein in colorectal carcinoma. In: Cancer. 1998 ; Vol. 82, No. 5. pp. 816-821.
@article{c0cbba0c9ae24a9386a621a1ea347805,
title = "Overexpression of elongation factor-1γ protein in colorectal carcinoma",
abstract = "BACKGROUND. Elongation factor-1 (EF-1) is a cellular protein that plays a role in protein synthesis by mediating the transfer of aminoacyl-tRNA to 80S ribosomes. It is comprised of four subunits: α, β, γ, and δ. EF-1γ is a substrate for the maturation-promoting factor, which determines entry into the M-phase of the cell cycle in all eukaryotic cells. Previously, the authors showed that EF-1γ RNA is overexpressed in a high proportion of colorectal carcinomas. At that time, there were no antibodies to EF-1γ, so the EF-1γ protein could not be examined. Because levels of RNA do not always parallel the levels of the protein it encodes, it was important to develop antibodies to EF-1γ to examine its expression at the protein level in colorectal carcinoma. METHODS. Twenty-nine patients undergoing surgical resection for colorectal adenocarcinoma were studied. A polyclonal antibody to EF-1γ in rabbit was prepared. Tumors and normal-appearing mucosa distant from the tumor (≤10 cm) were obtained from each patient. Cytosolic proteins were extracted from the tissues and examined by Western blot analysis with the EF-1γ antibody. Colonic tumors also were studied by immunohistochemical analysis with another EF-1γ polyclonal antibody. RESULTS. Using Western blot analysis, the authors observed greater expression of EF-1γ in the tumors than in the more distal normal-appearing mucosa. Overexpression was not observed in the patients with the two Dukes Stage A tumors, but was observed in four of ten patients with Dukes Stage B tumors, seven of eight patients with Dukes Stage C tumors, and six of nine patients with Dukes Stage D tumors. Overall, 17 of 29 patients (59{\%}) were found to have overexpression of EF-1γ. Using immunohistochemical analysis, EF-1γ protein was shown to be located predominantly in tumor epithelium rather than the stroma or infiltrating mononuclear cells. CONCLUSIONS. Previous studies showed that EF- 1γ mRNA frequently is overexpressed in colorectal adenocarcinoma. This study showed that EF-1γ also was overexpressed at the protein level in colorectal adenocarcinoma relative to more distal normal-appearing mucosa from the same patient. Immunohistochemical analysis demonstrated that this protein was expressed predominantly in the tumor epithelial cells and therefore was not derived from cells involved in the desmoplastic response.",
keywords = "Colon carcinoma, Elongation factor-1γ, Gene overexpression, Normal- appearing mucosa",
author = "Sandip Mathur and Cleary, {Karen R.} and Nikhil Inamdar and Kim, {Yeul Hong} and Peter Steck and Frazier, {Marsha L.}",
year = "1998",
month = "3",
day = "1",
doi = "10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H",
language = "English",
volume = "82",
pages = "816--821",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Overexpression of elongation factor-1γ protein in colorectal carcinoma

AU - Mathur, Sandip

AU - Cleary, Karen R.

AU - Inamdar, Nikhil

AU - Kim, Yeul Hong

AU - Steck, Peter

AU - Frazier, Marsha L.

PY - 1998/3/1

Y1 - 1998/3/1

N2 - BACKGROUND. Elongation factor-1 (EF-1) is a cellular protein that plays a role in protein synthesis by mediating the transfer of aminoacyl-tRNA to 80S ribosomes. It is comprised of four subunits: α, β, γ, and δ. EF-1γ is a substrate for the maturation-promoting factor, which determines entry into the M-phase of the cell cycle in all eukaryotic cells. Previously, the authors showed that EF-1γ RNA is overexpressed in a high proportion of colorectal carcinomas. At that time, there were no antibodies to EF-1γ, so the EF-1γ protein could not be examined. Because levels of RNA do not always parallel the levels of the protein it encodes, it was important to develop antibodies to EF-1γ to examine its expression at the protein level in colorectal carcinoma. METHODS. Twenty-nine patients undergoing surgical resection for colorectal adenocarcinoma were studied. A polyclonal antibody to EF-1γ in rabbit was prepared. Tumors and normal-appearing mucosa distant from the tumor (≤10 cm) were obtained from each patient. Cytosolic proteins were extracted from the tissues and examined by Western blot analysis with the EF-1γ antibody. Colonic tumors also were studied by immunohistochemical analysis with another EF-1γ polyclonal antibody. RESULTS. Using Western blot analysis, the authors observed greater expression of EF-1γ in the tumors than in the more distal normal-appearing mucosa. Overexpression was not observed in the patients with the two Dukes Stage A tumors, but was observed in four of ten patients with Dukes Stage B tumors, seven of eight patients with Dukes Stage C tumors, and six of nine patients with Dukes Stage D tumors. Overall, 17 of 29 patients (59%) were found to have overexpression of EF-1γ. Using immunohistochemical analysis, EF-1γ protein was shown to be located predominantly in tumor epithelium rather than the stroma or infiltrating mononuclear cells. CONCLUSIONS. Previous studies showed that EF- 1γ mRNA frequently is overexpressed in colorectal adenocarcinoma. This study showed that EF-1γ also was overexpressed at the protein level in colorectal adenocarcinoma relative to more distal normal-appearing mucosa from the same patient. Immunohistochemical analysis demonstrated that this protein was expressed predominantly in the tumor epithelial cells and therefore was not derived from cells involved in the desmoplastic response.

AB - BACKGROUND. Elongation factor-1 (EF-1) is a cellular protein that plays a role in protein synthesis by mediating the transfer of aminoacyl-tRNA to 80S ribosomes. It is comprised of four subunits: α, β, γ, and δ. EF-1γ is a substrate for the maturation-promoting factor, which determines entry into the M-phase of the cell cycle in all eukaryotic cells. Previously, the authors showed that EF-1γ RNA is overexpressed in a high proportion of colorectal carcinomas. At that time, there were no antibodies to EF-1γ, so the EF-1γ protein could not be examined. Because levels of RNA do not always parallel the levels of the protein it encodes, it was important to develop antibodies to EF-1γ to examine its expression at the protein level in colorectal carcinoma. METHODS. Twenty-nine patients undergoing surgical resection for colorectal adenocarcinoma were studied. A polyclonal antibody to EF-1γ in rabbit was prepared. Tumors and normal-appearing mucosa distant from the tumor (≤10 cm) were obtained from each patient. Cytosolic proteins were extracted from the tissues and examined by Western blot analysis with the EF-1γ antibody. Colonic tumors also were studied by immunohistochemical analysis with another EF-1γ polyclonal antibody. RESULTS. Using Western blot analysis, the authors observed greater expression of EF-1γ in the tumors than in the more distal normal-appearing mucosa. Overexpression was not observed in the patients with the two Dukes Stage A tumors, but was observed in four of ten patients with Dukes Stage B tumors, seven of eight patients with Dukes Stage C tumors, and six of nine patients with Dukes Stage D tumors. Overall, 17 of 29 patients (59%) were found to have overexpression of EF-1γ. Using immunohistochemical analysis, EF-1γ protein was shown to be located predominantly in tumor epithelium rather than the stroma or infiltrating mononuclear cells. CONCLUSIONS. Previous studies showed that EF- 1γ mRNA frequently is overexpressed in colorectal adenocarcinoma. This study showed that EF-1γ also was overexpressed at the protein level in colorectal adenocarcinoma relative to more distal normal-appearing mucosa from the same patient. Immunohistochemical analysis demonstrated that this protein was expressed predominantly in the tumor epithelial cells and therefore was not derived from cells involved in the desmoplastic response.

KW - Colon carcinoma

KW - Elongation factor-1γ

KW - Gene overexpression

KW - Normal- appearing mucosa

UR - http://www.scopus.com/inward/record.url?scp=0032031685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032031685&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H

DO - 10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H

M3 - Article

C2 - 9486568

AN - SCOPUS:0032031685

VL - 82

SP - 816

EP - 821

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -